» Articles » PMID: 15156481

Severe Acute Respiratory Syndrome

Overview
Journal Clin Infect Dis
Date 2004 May 25
PMID 15156481
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience.

Citing Articles

The Potential Mechanisms Behind Adverse Effect of Coronavirus Disease-19 on Heart and Liver Damage: A Review.

Daba T, Mokonon M, Niguse E, Getahun M Ethiop J Health Sci. 2024; 34(1):85-100.

PMID: 38957334 PMC: 11217793. DOI: 10.4314/ejhs.v34i1.10.


Natural and Synthetic Coumarins as Potential Drug Candidates against SARS-CoV-2/COVID-19.

da Silva Santos I, Magalhaes L, Marra R, Lima C, Hamerski L, Albuquerque M Curr Med Chem. 2024; 32(3):539-562.

PMID: 38243979 DOI: 10.2174/0109298673285609231220111556.


Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.

Bert N, Samandari T Cell Mol Immunol. 2024; 21(2):159-170.

PMID: 38221577 PMC: 10805869. DOI: 10.1038/s41423-024-01127-z.


Autonomous swab robot for naso- and oropharyngeal COVID-19 screening.

Haddadin S, Wilhelm D, Wahrmann D, Tenebruso F, Sadeghian H, Naceri A Sci Rep. 2024; 14(1):142.

PMID: 38167977 PMC: 10762007. DOI: 10.1038/s41598-023-50291-1.


The chaos law is a principal driver of natural selection: A proposition on the evolution of recently emerged coronaviruses.

Roggero P, Calistri A, Palu G PLoS One. 2023; 18(8):e0290453.

PMID: 37616261 PMC: 10449193. DOI: 10.1371/journal.pone.0290453.


References
1.
Wong K, Antonio G, Hui D, Lee N, Yuen E, Wu A . Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease. Radiology. 2003; 228(2):395-400. DOI: 10.1148/radiol.2283030541. View

2.
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr H . Treatment of SARS with human interferons. Lancet. 2003; 362(9380):293-4. PMC: 7112413. DOI: 10.1016/s0140-6736(03)13973-6. View

3.
Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1967-76. DOI: 10.1056/NEJMoa030747. View

4.
Rainer T, Cameron P, Smit D, Ong K, Hung A, Nin D . Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ. 2003; 326(7403):1354-8. PMC: 162123. DOI: 10.1136/bmj.326.7403.1354. View

5.
Hon K, Leung C, Cheng W, Chan P, Chu W, Kwan Y . Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003; 361(9370):1701-3. PMC: 7112484. DOI: 10.1016/s0140-6736(03)13364-8. View